The McKnight Scholar Awards support neuroscientists in the early stages of their careers.
The McKnight Scholar Awards are given to exceptional young scientists who are in the early stages of establishing an independent laboratory and research career. The Scholar Awards have been given annually since 1977. They were the McKnight Foundation’s earliest means of supporting neuroscience research. The intent of the program is to foster the commitment by these scientists to research careers that will have an important impact on the study of the brain. The program seeks to support scientists committed to mentoring neuroscientists from underrepresented groups at all levels of training. Applicants for the McKnight Scholar Award must demonstrate their ability to solve significant problems in neuroscience, which may include the translation of basic research to clinical practice. They should demonstrate a commitment to an equitable and inclusive lab environment.
McKnight Scholars have generated some key findings about neuroscience, including:
Intellectual property rights resulting from the research – including patents, copyrights, processes, or formulae – will be retained by the institution of the awardee. The information derived from the research will be published in a form that is available to the interested public and made available to the public on a nondiscriminatory basis.
Benefits
In this competition, up to ten McKnight Scholars will be selected to receive three years of support, beginning June 1, 2027. The total award is $225,000 paid in equal installments of $75,000 in 2027, 2028, and 2029. Allowable budget items include salaries and fringe benefits, tuition, equipment, supplies, animal costs, costs for technical services, etc. Funds cannot be used for indirect costs.
Most McKnight award winners will tell you that a huge benefit of receiving a McKnight award is the chance to join a community of the nation’s best neuroscientists that they will continue to learn from, interact and collaborate with over their lifetime. Award winners attend the McKnight Conference on Neuroscience for the three years after receiving the award, and then return to the conference every three years. No other community in neuroscience has this kind of longitudinal impact and that demonstrates such a strong sense of community.
The conference has met in Aspen, Colorado since 1998, and invites over 100 current and previous McKnight awardees every year. The bulk of the conference involves third year current awardees sharing the results of their research and ample opportunities for informal scientific discussion to fuel new ideas and collaborations. An entire session is devoted to a neurological disorder (e.g. Alzheimer’s, Autism, Depression, among others) with specialists invited to speak and host a Q & A.
1. ⭐⭐⭐⭐⭐ A genuinely important neuroscience question
This is the fundamental predictor.
McKnight's Scholar guidance asks applicants to make the central scientific question immediately clear and explain why someone outside the applicant's specialty should care about it. The NBD program similarly requires a clear clinical problem and specific aims.
Strong proposal characteristics:
Weak approach:
"Study X because it has not been studied."
Stronger approach:
"Resolve a fundamental mechanism that could change how a major neurological disorder is understood."
2. ⭐⭐⭐⭐⭐ Innovation and distinctive scientific viewpoint
McKnight places unusually strong emphasis on creative, original science.
For Scholar Awards, the proposed work should represent one of the laboratory's most innovative and impactful directions. The FAQ specifically asks applicants to demonstrate a distinctive scientific viewpoint.
Recent 2026 Scholar awardees illustrate this breadth: projects involve neural computation, social behavior, motor control, neural evolution, transcriptional mechanisms, and computational approaches to high-dimensional neural data.
High-value innovation includes:
3. ⭐⭐⭐⭐⭐ Transformative potential / ability to change understanding
McKnight is particularly interested in research that could produce a substantial conceptual advance, rather than simply adding another dataset.
The Scholar FAQ explicitly encourages ambitious work and asks applicants to explain the best-case scenario for what the field will understand if the research succeeds.
A strong proposal should therefore answer:
If this works, what will neuroscientists understand that they cannot understand today?
For NBD proposals, this becomes:
How could the mechanistic discovery ultimately improve diagnosis, prevention, treatment, or cure?
The NBD program specifically asks applicants to explain how their research will translate biological discoveries into improved human health.
4. ⭐⭐⭐⭐⭐ Scientific rigor + credible experimental strategy
McKnight does not require an applicant to eliminate scientific risk. In fact, the Scholar FAQ says intellectual risk can be high, provided that the proposed approach is credible and there is a compelling reason to believe the central ideas can be tested.
Strong applications therefore balance:
Ambition + feasibility + rigorous testing
Important elements include:
For ambitious new directions, preliminary evidence is not mandatory, but McKnight says it can help demonstrate feasibility.
5. ⭐⭐⭐⭐⭐ Strong fit with the specific McKnight award
There are two substantially different routes.
| Award | Strongest scientific fit |
|---|---|
| Neurobiology of Brain Disorders Award | Biological mechanisms of neurological/psychiatric disorders with potential translation toward diagnosis, prevention or treatment |
| McKnight Scholar Award | Fundamental neuroscience by early-career independent investigators, with potential for important advances in understanding the brain |
The NBD program explicitly focuses on biological mechanisms of neurological and psychiatric disorders.
The Scholar program is aimed at scientists in the early stages of establishing independent laboratories and research careers.
Important: A technically excellent project can still be poorly positioned if it does not fit the particular award mechanism.
6. ⭐⭐⭐⭐☆ Applicant's demonstrated ability to execute the science
McKnight evaluates not only the idea but whether the laboratory can actually deliver it.
Its Scholar checklist asks applicants to show that their lab can achieve results through evidence such as:
For NBD applications, applicants submit NIH biosketches and representative previous publications; the committee invites only a small group of applications to interview.
Success predictor:
The proposal should make a convincing connection between:
Past expertise → proposed approach → ability to deliver the discovery
7. ⭐⭐⭐⭐☆ Ambition balanced with tractability
McKnight explicitly asks applicants to think differently from conventional grant-writing approaches.
The Scholar FAQ says proposals may be highly ambitious and intellectually risky, but the approach must remain credible. Applicants should show why the critical ideas can actually be tested.
Therefore, avoid both extremes:
Too conservative:
Small incremental experiment unlikely to change the field.
Too speculative:
Huge vision with no credible critical experiment.
Ideal:
High-risk/high-reward scientific question + a small number of decisive experiments.
8. ⭐⭐⭐⭐☆ Clear communication to scientists outside the specialty
This is particularly important for McKnight.
The Scholar application guidance asks:
Why should someone from outside your field care about your research?
The six-point checklist also asks whether the central question is easy to identify and whether the applicant has clearly explained the significance of the work.
A successful application should therefore be understandable to a broad neuroscience review committee, not just experts in the applicant's narrow subfield.
Use:
Problem → Knowledge gap → New idea → Critical experiment → Expected discovery → Broader significance
9. ⭐⭐⭐⭐☆ Commitment to an equitable and inclusive scientific environment
This is not merely a generic institutional statement.
McKnight explicitly states that it seeks applicants committed to mentoring neuroscientists from underrepresented groups and equitable, inclusive laboratory environments.
The Scholar application requires a Diversity & Inclusion Statement describing specific actions taken beyond the confines of the laboratory, with emphasis on personal experience and concrete actions rather than only philosophy.
For NBD applicants, commitment to equitable and inclusive lab environments is also explicitly part of the award description.
Strong evidence:
10. ⭐⭐⭐⭐☆ Career stage and eligibility alignment
Eligibility is a major practical predictor because McKnight's awards are deliberately designed for particular career stages.
For the 2027 Scholar Award, applicants must be independent investigators at U.S. nonprofit research institutions and Assistant Professors (or equivalent) who have served at that rank for less than five years. The current eligibility cutoff means the Assistant Professor appointment cannot have started before December 1, 2021, subject to permitted exceptions.
For the 2027 NBD Award, investigators must be independent investigators at U.S. nonprofit research institutions and have held a tenured or tenure-track faculty position for at least three years.
Thus, career-stage fit is not a minor administrative issue—it determines which McKnight competition an investigator can enter.
The McKnight Scholar Awards are given to exceptional young scientists who are in the early stages of establishing an independent laboratory and research career.
Eligible Countries:
Sponsor Institute/Organizations: McKnight Endowment Fund for Neuroscience
Sponsor Type: Corporate/Non-Profit
Address: 921 Washington Avenue South Minneapolis, MN 55415
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Nov 03, 2026
Nov 03, 2026
$225,000
Affiliation: McKnight Endowment Fund for Neuroscience
Address: 921 Washington Avenue South Minneapolis, MN 55415
Website URL: https://www.mcknight.org/programs/the-mcknight-endowment-fund-for-neuroscience/scholar-awards/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.